Tropocells® PRP
The Tropocells® PRP system utilizes a patented separator gel technology to isolate the platelets while eliminating the undesirable components such as red blood cells and inflammatory white blood cells.
TropoVisc®
TropoVisc® is an autologous, biological cell carrier for growth factor release. TropoVisc® uses the slow reabsorption properties of denaturized plasmatic proteins to maintain the renowned efficacy of Tropocells® PRP for a longer time at the place of injection.
Tropocells® PRF
Tropocells® PRF creates a fibrin scaffold in which growth factors and other bioactive materials interact to stimulate the healing process. The pure Tropocells® PRF is generated following platelet activation, with the platelets becoming trapped within this matrix.
Tropocells® TRS
The combination of Tropocells® TRS and Tropocells® PRP releases enriched growth factors that stimulate, accelerate, and enhance the body’s natural healing processes at specific, localized surgical sites.
Tropocells® PRFM
(Platelet Rich Fibrin Matrix) is a fibrin gel matrix that is derived by combining Tropocells® PRP with autologous thrombin. Tropocells® TRS (Thrombin Rich Serum) is a major byproduct of Tropocells® PRF.
+30
Years of experience
SINCE 1994
Committed to quality and innovation
Tropocells® sets the standard in medical device innovation, offering advanced products for autologous regenerative medicine.
We are part of Estar Medical®, which has been developing medical technology for over 30 years, driving advancements through the integration of research, expert insights, and innovative therapies.